Japanese subgroup analysis in the Asian phase II study of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma
- Eiju Negoro
- , Takahiro Yamauchi
- , Noriko Fukuhara
- , Kazuhito Yamamoto
- , Toshiki Uchida
- , Koji Izutsu
- , Dai Maruyama
- , Yasuhito Terui
- , Hideaki Nakajima
- , Kiyoshi Ando
- , Youko Suehiro
- , Ilseung Choi
- , Nobuhiro Kanemura
- , Nobuhiko Nakamura
- , Go Yamamoto
- , Yoshinobu Maeda
- , Hirohiko Shibayama
- , Fumiko Nagahama
- , Yusuke Sonehara
- , Hirokazu Nagai
- University of Fukui
- Tohoku University
- Aichi Cancer Center Hospital and Research Institute
- Japanese Red Cross Nagoya Daini Hospital
- National Cancer Center Japan
- Japanese Foundation for Cancer Research
- Yokohama City University
- Tokai University
- National Hospital Organization Kyushu Cancer Center
- Gifu University
- Toranomon Hospital
- Okayama University
- The University of Osaka
- Solasia Pharma K.K
- National Hospital Organization Nagoya Medical Center
- National Taiwan University
- Queen Mary Hospital Hong Kong
Research output: Contribution to journal › Article › peer-review
3
Link opens in a new tab
Scopus
citations